Analyze Diet

Preanalytical variables affecting the measurement of serum paraoxonase-1 activity in horses.

Abstract: Paraoxonase-1 (PON-1) activity is a new inflammatory and oxidative marker. Technical effects and biological factors could affect the accuracy of PON-1 activity measurement. We investigated the effects of storage at different temperatures, repeated freeze-thaw cycles, interferences from hemolytic, lipemic, and icteric samples, and seasonal effects on PON-1 activity in horses. We evaluated 2 substrates with an automated spectrophotometer. Ten equine serum samples were stored under different conditions. Although storage at room (21°C) or refrigeration (4°C) temperature induced a statistically significant decrease ( < 0.05) in PON-1 activity, this is not diagnostically relevant. PON-1 activity in frozen samples (-20°C) was stable for short-term storage; diagnostically significant ( < 0.01) fluctuations were observed after 1 mo. Four repeated freeze-thaw cycles were assessed, and all cycles affected PON-1 activity ( < 0.01); however, this was diagnostically significant only after the 4th cycle. Hemolysis induced an overestimation of PON-1 activity; lipemia and hyperbilirubinemia did not change PON-1 activity. Thirty-four horses were sampled monthly for 1 y, and PON-1 activity was higher in autumn ( < 0.05) and winter ( < 0.05) than in spring and summer.
Publication Date: 2020-11-22 PubMed ID: 33225843PubMed Central: PMC7758704DOI: 10.1177/1040638720974745Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Evaluation Study
  • Journal Article
  • Multicenter Study

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article is focused on investigating the preanalytical factors affecting the measurement of Paraoxonase-1 (PON-1) activity in horses, an important new marker for inflammation and oxidation.

Study Overview

In the study, the authors explored how technical and biological factors could potentially influence the accuracy of PON-1 activity measurement in horses. They assessed the impact of different storage temperatures, the number of freeze-thaw cycles, interferences from hemolytic, lipemic, and icteric samples, as well as seasonal effects.

Storage Conditions and Temperature

  • The researchers sampled ten equine serum samples stored under varying conditions.
  • They found that keeping the samples at room temperature (21°C) or refrigerated (4°C) led to a statistically significant decrease in PON-1 activity. However, this decrease was not considered diagnostically relevant.
  • Frozen samples (-20°C) remained stable for short-term storage; nevertheless, significant fluctuations in PON-1 activity were observed after one month.

Freeze-Thaw Cycles

  • The study evaluated the effects of repeated freeze-thaw cycles on the PON-1 activity measurement.
  • All cycles affected PON-1 activity, but this effect was diagnostically significant only after the fourth cycle.

Hemolysis and Hyperbilirubinemia

  • The interference from hemolytic samples was evaluated, and it was found to cause an overestimation in PON-1 activity measurements.
  • In contrast, lipemia and hyperbilirubinemia did not have any impact on PON-1 activity, according to the study results.

Seasonal Variations

  • 34 horses were sampled monthly for a year to examine the effect of seasonal variations.
  • It was found that PON-1 activity was higher during autumn and winter than in spring and summer, which showed a significant seasonal effect on PON-1 activity levels in horses.

Cite This Article

APA
Rossi G, Richardson A, Jamaludin H, Secombe C. (2020). Preanalytical variables affecting the measurement of serum paraoxonase-1 activity in horses. J Vet Diagn Invest, 33(1), 59-66. https://doi.org/10.1177/1040638720974745

Publication

ISSN: 1943-4936
NlmUniqueID: 9011490
Country: United States
Language: English
Volume: 33
Issue: 1
Pages: 59-66

Researcher Affiliations

Rossi, Gabriele
  • School of Veterinary Medicine, College of Science, Health, Engineering and Education, Murdoch University, Murdoch, Western Australia, Australia.
Richardson, Amy
  • School of Veterinary Medicine, College of Science, Health, Engineering and Education, Murdoch University, Murdoch, Western Australia, Australia.
Jamaludin, Hali
  • School of Veterinary Medicine, College of Science, Health, Engineering and Education, Murdoch University, Murdoch, Western Australia, Australia.
Secombe, Cristy
  • School of Veterinary Medicine, College of Science, Health, Engineering and Education, Murdoch University, Murdoch, Western Australia, Australia.

MeSH Terms

  • Animals
  • Aryldialkylphosphatase / blood
  • Australia
  • Biomarkers / blood
  • Freezing
  • Horses / blood
  • Specimen Handling / veterinary
  • Temperature

Conflict of Interest Statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

This article includes 38 references
  1. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.. J Clin Invest 1998 Apr 15;101(8):1581-90.
    pmc: PMC508738pubmed: 9541487doi: 10.1172/jci1649google scholar: lookup
  2. Billecke S, Draganov D, Counsell R, Stetson P, Watson C, Hsu C, La Du BN. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters.. Drug Metab Dispos 2000 Nov;28(11):1335-42.
    pubmed: 11038162
  3. Braun JP, Bourgès-Abella N, Geffré A, Concordet D, Trumel C. The preanalytic phase in veterinary clinical pathology.. Vet Clin Pathol 2015 Mar;44(1):8-25.
    pubmed: 25438659doi: 10.1111/vcp.12206google scholar: lookup
  4. Camps J, Marsillach J, Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement.. Crit Rev Clin Lab Sci 2009;46(2):83-106.
    pubmed: 19255916doi: 10.1080/10408360802610878google scholar: lookup
  5. Ceron JJ, Tecles F, Tvarijonaviciute A. Serum paraoxonase 1 (PON1) measurement: an update.. BMC Vet Res 2014 Mar 25;10:74.
    pmc: PMC3985595pubmed: 24666514doi: 10.1186/1746-6148-10-74google scholar: lookup
  6. Cuhadar S, Koseoglu M, Atay A, Dirican A. The effect of storage time and freeze-thaw cycles on the stability of serum samples.. Biochem Med (Zagreb) 2013;23(1):70-7.
    pmc: PMC3900085pubmed: 23457767doi: 10.11613/bm.2013.009google scholar: lookup
  7. Farid AS, Honkawa K, Fath EM, Nonaka N, Horii Y. Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows.. BMC Vet Res 2013 Apr 11;9:73.
    pmc: PMC3637055pubmed: 23578174doi: 10.1186/1746-6148-9-73google scholar: lookup
  8. Fazio E, Medica P, Cravana C, Bruschetta G, Ferlazzo A. Seasonal thyroid and lipid profiles in Thoroughbred pregnant and nonpregnant mares (Equus caballus).. Theriogenology 2016 Jun;85(9):1582-1589.
  9. Feingold KR, Memon RA, Moser AH, Grunfeld C. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response.. Atherosclerosis 1998 Aug;139(2):307-15.
    pubmed: 9712337doi: 10.1016/s0021-9150(98)00084-7google scholar: lookup
  10. Flatland B, Freeman KP, Friedrichs KR, Vap LM, Getzy KM, Evans EW, Harr KE. ASVCP quality assurance guidelines: control of general analytical factors in veterinary laboratories.. Vet Clin Pathol 2010 Sep;39(3):264-77.
  11. Frank N, Elliott SB, Chameroy KA, Tóth F, Chumbler NS, McClamroch R. Association of season and pasture grazing with blood hormone and metabolite concentrations in horses with presumed pituitary pars intermedia dysfunction.. J Vet Intern Med 2010 Sep-Oct;24(5):1167-75.
  12. Furlong CE. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.. J Biochem Mol Toxicol 2007;21(4):197-205.
    pubmed: 17936934doi: 10.1002/jbt.20181google scholar: lookup
  13. Glick MR. Interferographs: A User’s Guide to Interferences in Clinical Chemistry Instruments. 2nd ed. Science Enterprises, 1991.
  14. Glick MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation.. Clin Chem 1986 Mar;32(3):470-5.
    pubmed: 3948389
  15. Gunn-Christie RG, Flatland B, Friedrichs KR, Szladovits B, Harr KE, Ruotsalo K, Knoll JS, Wamsley HL, Freeman KP. ASVCP quality assurance guidelines: control of preanalytical, analytical, and postanalytical factors for urinalysis, cytology, and clinical chemistry in veterinary laboratories.. Vet Clin Pathol 2012 Mar;41(1):18-26.
  16. Haagen L, Brock A. A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate.. Eur J Clin Chem Clin Biochem 1992 Jul;30(7):391-5.
    pubmed: 1525262doi: 10.1515/cclm.1992.30.7.391google scholar: lookup
  17. Harr KE, Flatland B, Nabity M, Freeman KP. ASVCP guidelines: allowable total error guidelines for biochemistry.. Vet Clin Pathol 2013 Dec;42(4):424-36.
    pubmed: 24320779doi: 10.1111/vcp.12101google scholar: lookup
  18. Hooijberg E, Leidinger E, Freeman KP. An error management system in a veterinary clinical laboratory.. J Vet Diagn Invest 2012 May;24(3):458-68.
    pubmed: 22529112doi: 10.1177/1040638712441782google scholar: lookup
  19. International Organization for Standardization. ISO 15189: 2012. Medical Laboratories—Requirements for Quality and Competence. ISO, 2012.
  20. Jacobs RM, Lumsden JH, Grift E. Effects of bilirubinemia, hemolysis, and lipemia on clinical chemistry analytes in bovine, canine, equine, and feline sera.. Can Vet J 1992 Sep;33(9):605-8.
    pmc: PMC1481322pubmed: 17424077
  21. Kotani K, Sakane N, Sano Y, Tsuzaki K, Matsuoka Y, Egawa K, Yoshimura M, Horikawa C, Kitagawa Y, Kiso Y, Kimura S, Schulze J, Taing J, Gugliucci A. Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women.. J Clin Biochem Nutr 2009 Nov;45(3):329-34.
    pmc: PMC2771255pubmed: 19902024doi: 10.3164/jcbn.09-26google scholar: lookup
  22. Mackness B, Hine D, Liu Y, Mastorikou M, Mackness M. Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells.. Biochem Biophys Res Commun 2004 Jun 4;318(3):680-3.
    pubmed: 15144891doi: 10.1016/j.bbrc.2004.04.056google scholar: lookup
  23. Marsillach J, Aragonès G, Beltrán R, Caballeria J, Pedro-Botet J, Morcillo-Suárez C, Navarro A, Joven J, Camps J. The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment.. Clin Biochem 2009 Jan;42(1-2):91-8.
  24. Martínez-Subiela S, Cerón JJ. Effects of hemolysis, lipemia, hyperbilirrubinemia, and anticoagulants in canine C-reactive protein, serum amyloid A, and ceruloplasmin assays.. Can Vet J 2005 Jul;46(7):625-9.
    pmc: PMC1168879pubmed: 16152718
  25. McFarlane D. Diagnostic Testing for Equine Endocrine Diseases: Confirmation Versus Confusion.. Vet Clin North Am Equine Pract 2019 Aug;35(2):327-338.
    pubmed: 31076223doi: 10.1016/j.cveq.2019.03.005google scholar: lookup
  26. Novak F, Vavrova L, Kodydkova J, Novak F Sr, Hynkova M, Zak A, Novakova O. Decreased paraoxonase activity in critically ill patients with sepsis.. Clin Exp Med 2010 Mar;10(1):21-5.
    pubmed: 19760042doi: 10.1007/s10238-009-0059-8google scholar: lookup
  27. O'Neill SL, Feldman BF. Hemolysis as a factor in clinical chemistry and hematology of the dog.. Vet Clin Pathol 1989;18(3):58-68.
  28. Radakovic M, Davitkov D, Borozan S, Stojanovic S, Stevanovic J, Krstic V, Stanimirovic Z. Oxidative stress and DNA damage in horses naturally infected with Theileria equi.. Vet J 2016 Nov;217:112-118.
    pubmed: 27810201doi: 10.1016/j.tvjl.2016.10.003google scholar: lookup
  29. Robie SM, Janson CH, Smith SC, O'Connor JT Jr. Equine serum lipids: serum lipids and glucose in Morgan and Thoroughbred horses and Shetland ponies.. Am J Vet Res 1975 Dec;36(12):1705-8.
    pubmed: 1200441
  30. Rossi G, Giordano A, Pezzia F, Kjelgaard-Hansen M, Paltrinieri S. Serum paraoxonase 1 activity in dogs: preanalytical and analytical factors and correlation with C-reactive protein and alpha-2-globulin.. Vet Clin Pathol 2013 Sep;42(3):329-41.
    pubmed: 23944371doi: 10.1111/vcp.12073google scholar: lookup
  31. Rossi S, Rossi G, Giordano A, Paltrinieri S. Homocysteine measurement by an enzymatic method and potential role of homocysteine as a biomarker in dogs.. J Vet Diagn Invest 2008 Sep;20(5):644-9.
    pubmed: 18776102doi: 10.1177/104063870802000520google scholar: lookup
  32. Rubio CP, Tvarijonaviciute A, Caldin M, Hernández-Ruiz J, Cerón JJ, Martínez-Subiela S, Tecles F. Stability of biomarkers of oxidative stress in canine serum.. Res Vet Sci 2018 Dec;121:85-93.
    pubmed: 30359815doi: 10.1016/j.rvsc.2018.09.007google scholar: lookup
  33. Ruggerone B, Bonelli F, Nocera I, Paltrinieri S, Giordano A, Sgorbini M. Validation of a paraoxon-based method for measurement of paraoxonase (PON-1) activity and establishment of RIs in horses.. Vet Clin Pathol 2018 Mar;47(1):69-77.
    pubmed: 29575140doi: 10.1111/vcp.12562google scholar: lookup
  34. Secombe CJ, Tan RHH, Perara DI, Byrne DP, Watts SP, Wearn JG. The Effect of Geographic Location on Circannual Adrenocorticotropic Hormone Plasma Concentrations in Horses in Australia.. J Vet Intern Med 2017 Sep;31(5):1533-1540.
    pmc: PMC5598888pubmed: 28661009doi: 10.1111/jvim.14782google scholar: lookup
  35. Turk R, Habuš J, Flegar-Meštrić Z, Svetina A, Mojčec V, Perkov S, Belić M, Starešina V, Turk N. Serum platelet-activating factor acetylhydrolase and paraoxonase-1 activity in horses infected with Leptospira spp.. Acta Trop 2011 May;118(2):97-100.
  36. Tvarijonaviciute A, Tecles F, Caldin M, Tasca S, Cerón J. Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs.. Am J Vet Res 2012 Jan;73(1):34-41.
    pubmed: 22204286doi: 10.2460/ajvr.73.1.34google scholar: lookup
  37. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.. J Clin Invest 1995 Dec;96(6):2882-91.
    pmc: PMC185999pubmed: 8675659doi: 10.1172/jci118359google scholar: lookup
  38. West J, Atherton J, Costelloe SJ, Pourmahram G, Stretton A, Cornes M. Preanalytical errors in medical laboratories: a review of the available methodologies of data collection and analysis.. Ann Clin Biochem 2017 Jan;54(1):14-19.
    pubmed: 27614351doi: 10.1177/0004563216669384google scholar: lookup

Citations

This article has been cited 1 times.
  1. Thompson EW, Demissei BG, Smith AM, Brahmbhatt P, Wang J, Clark A, DeMichele A, Narayan V, Shah P, Sun L, Lefebvre B, Fradley MG, Carver JR, Tang WHW, Ky B. Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab.. JACC Basic Transl Sci 2022 Jan;7(1):1-10.
    doi: 10.1016/j.jacbts.2021.10.010pubmed: 35128203google scholar: lookup